Type 1 diabetes rates are rising, but breakthrough drugs and devices are changing what it means to live with the disease.

More information: Viral N. Shah et al, Semaglutide in Adults with Type 1 Diabetes and Obesity, NEJM Evidence (2025). DOI: 10.1056/EVIDoa2500173 Provided by Oregon Health & Science University ...

Use of an automated insulin delivery system that combines an insulin pump with a disposable sensor improved time in range and ...

CHICAGO — Once-weekly semaglutide improved glycemia and reduced weight without increasing hypoglycemia in adults with type 1 diabetes (T1D) and obesity, new research presented at the American ...

Diabetes is a growing serious health problem globally, the risk of which is being seen in people of all ages. Our changing lifestyle, irregular eating habits, and stress have made this disease common.

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.